Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 137823, 17 pages
http://dx.doi.org/10.1155/2015/137823
Review Article

Transforming Growth Factor Beta Family: Insight into the Role of Growth Factors in Regulation of Fracture Healing Biology and Potential Clinical Applications

1Department of General and Experimental Pathology with Centre for Preclinical Research and Technology (CePT), Second Faculty of Medicine, Medical University of Warsaw, Pawińskiego 3c, 02-106 Warsaw, Poland
2Department of Rheumaorthopaedics, Institute of Rheumatology, Spartańska 1, 02-637 Warsaw, Poland
3Department of Neuroorthopaedics and Neurology, Institute of Rheumatology, Spartańska 1, 02-637 Warsaw, Poland

Received 4 September 2014; Accepted 9 November 2014

Academic Editor: Philip Stahel

Copyright © 2015 Łukasz A. Poniatowski et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. D. Woolf, T. Vos, and L. March, “How to measure the impact of musculoskeletal conditions,” Best Practice & Research Clinical Rheumatology, vol. 24, no. 6, pp. 723–732, 2010. View at Publisher · View at Google Scholar
  2. A. D. Woolf, P. Brooks, K. Akesson, and G. M. Mody, “Prevention of musculoskeletal conditions in the developing world,” Best Practice & Research Clinical Rheumatology, vol. 22, no. 4, pp. 759–772, 2008. View at Publisher · View at Google Scholar
  3. C. B. de Mattos, O. Binitie, and J. P. Dormans, “Pathological fractures in children,” Bone & Joint Research, vol. 1, no. 10, pp. 272–280, 2012. View at Publisher · View at Google Scholar
  4. F. Tull and J. Borrelli Jr., “Soft-tissue injury associated with closed fractures: evaluation and management,” The Journal of the American Academy of Orthopaedic Surgeons, vol. 11, no. 6, pp. 431–438, 2003. View at Google Scholar · View at Scopus
  5. H.-C. Pape, R. Marcucio, C. Humphrey, C. Colnot, M. Knobe, and E. J. Harvey, “Trauma-induced inflammation and fracture healing,” Journal of Orthopaedic Trauma, vol. 24, no. 9, pp. 522–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Hildebrand, H. C. Pape, and C. Krettek, “The importance of cytokines in the posttraumatic inflammatory reaction,” Commons below Unfallchirurg, vol. 108, no. 10, pp. 793–803, 2005. View at Google Scholar
  7. R. Pfeifer, S. Darwiche, L. Kohut, T. R. Billiar, and H.-C. Pape, “Cumulative effects of bone and soft tissue injury on systemic inflammation: a pilot study,” Clinical Orthopaedics and Related Research, vol. 471, no. 9, pp. 2815–2821, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Bastian, J. Pillay, J. Alblas, L. Leenen, L. Koenderman, and T. Blokhuis, “Systemic inflammation and fracture healing,” Journal of Leukocyte Biology, vol. 89, no. 5, pp. 669–673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Kobbe, Y. Vodovotz, D. J. Kaczorowski, T. R. Billiar, and H.-C. Pape, “The role of fracture-associated soft tissue injury in the induction of systemic inflammation and remote organ dysfunction after bilateral femur fracture,” Journal of Orthopaedic Trauma, vol. 22, no. 6, pp. 385–390, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Rochman, R. Spolski, and W. J. Leonard, “New insights into the regulation of T cells by γc family cytokines,” Nature Reviews Immunology, vol. 9, no. 7, pp. 480–490, 2009. View at Publisher · View at Google Scholar
  11. F. R. Balkwill and F. Burke, “The cytokine network,” Immunology Today, vol. 10, no. 9, pp. 299–304, 1989. View at Publisher · View at Google Scholar · View at Scopus
  12. Z. Frankenstein, U. Alon, and I. R. Cohen, “The immune-body cytokine network defines a social architecture of cell interactions,” Biology Direct, vol. 1, article 32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Lee, “Stem cell therapy independent of stemness,” World Journal of Stem Cells, vol. 4, no. 12, pp. 120–124, 2012. View at Publisher · View at Google Scholar
  14. D. Javelaud and A. Mauviel, “Mammalian transforming growth factor-βs: smad signaling and physio-pathological roles,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 7, pp. 1161–1165, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. R. I. Clark, K. J. Woodcock, F. Geissmann, C. Trouillet, and M. S. Dionne, “Multiple TGF-β superfamily signals modulate the adult drosophila immune response,” Current Biology, vol. 21, no. 19, pp. 1672–1677, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. K. W. Finnson, S. McLean, G. M. Di Guglielmo, and A. Philip, “Dynamics of transforming growth factor beta signaling in wound healing and scarring,” Advances in Skin & Wound Care, vol. 2, no. 5, pp. 195–214, 2013. View at Google Scholar
  17. J. W. Penn, A. O. Grobbelaar, and K. J. Rolfe, “The role of the TGF-β family in wound healing, burns and scarring: a review,” International Journal of Burns and Trauma, vol. 2, no. 1, pp. 18–28, 2012. View at Google Scholar
  18. M. C. Fleisch, C. A. Maxwell, and M.-H. Barcellos-Hoff, “The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs,” Endocrine-Related Cancer, vol. 13, no. 2, pp. 379–400, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Devescovi, E. Leonardi, G. Ciapetti, and E. Cenni, “Growth factors in bone repair,” La Chirurgia degli Organi di Movimento, vol. 92, no. 3, pp. 161–168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Lehnert and R. J. Akhurst, “Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action,” Development, vol. 104, no. 2, pp. 263–273, 1988. View at Google Scholar · View at Scopus
  21. A. Horner, P. Kemp, C. Summers et al., “Expression and distribution of transforming growth factor-β isoforms and their signaling receptors in growing human bone,” Bone, vol. 23, no. 2, pp. 95–102, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Vortkamp, S. Pathi, G. M. Peretti, E. M. Caruso, D. J. Zaleske, and C. J. Tabin, “Recapitulation of signals regulating embryonic bone formation during postnatal growth and in fracture repair,” Mechanisms of Development, vol. 71, no. 1-2, pp. 65–76, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Ferguson, E. Alpern, T. Miclau, and J. A. Helms, “Does adult fracture repair recapitulate embryonic skeletal formation?” Mechanisms of Development, vol. 87, no. 1-2, pp. 57–66, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. G. L. Barnes, P. J. Kostenuik, L. C. Gerstenfeld, and T. A. Einhorn, “Growth factor regulation of fracture repair,” Journal of Bone and Mineral Research, vol. 14, no. 11, pp. 1805–1815, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Wildemann, G. Schmidmaier, S. Ordel, R. Stange, N. P. Haas, and M. Raschke, “Cell proliferation and differentiation during fracture healing are influenced by locally applied IGF-I and TGF-beta1: comparison of two proliferation markers , PCNA and BrdU,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 65, no. 1, pp. 150–156, 2003. View at Google Scholar · View at Scopus
  26. K. Sarahrudi, A. Thomas, M. Mousavi et al., “Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing,” Injury, vol. 42, no. 8, pp. 833–837, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. P. V. Giannoudis, I. Pountos, J. Morley, S. Perry, H. I. Tarkin, and H.-C. Pape, “Growth factor release following femoral nailing,” Bone, vol. 42, no. 4, pp. 751–757, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. M. E. Joyce, S. Jingushi, and M. E. Bolander, “Transforming growth factor-β in the regulation of fracture repair,” Orthopedic Clinics of North America, vol. 21, no. 1, pp. 199–209, 1990. View at Google Scholar · View at Scopus
  29. E. Tsiridis, N. Upadhyay, and P. Giannoudis, “Molecular aspects of fracture healing: which are the important molecules?” Injury, vol. 38, no. 1, pp. S11–S25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. E. de Larco and G. J. Todaro, “Growth factors from murine sarcoma virus-transformed cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 75, no. 8, pp. 4001–4005, 1978. View at Publisher · View at Google Scholar · View at Scopus
  31. A. B. Roberts, M. A. Anzano, L. C. Lamb, J. M. Smith, and M. B. Sporn, “New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, no. 9, pp. 5339–5343, 1981. View at Publisher · View at Google Scholar · View at Scopus
  32. M. A. Anzano, A. B. Roberts, C. A. Meyers et al., “Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells,” Cancer Research, vol. 42, no. 11, pp. 4776–4778, 1982. View at Google Scholar · View at Scopus
  33. D. Fujii, J. E. Brissenden, R. Derynck, and U. Francke, “Transforming growth factor β gene maps to human chromosome 19 long arm and to mouse chromosome 7,” Somatic Cell and Molecular Genetics, vol. 12, no. 3, pp. 281–288, 1986. View at Publisher · View at Google Scholar · View at Scopus
  34. D. E. Barton, B. E. Foellmer, J. Du, J. Tamm, R. Derynck, and U. Francke, “Chromosomal mapping of genes for transforming growth factors β2 and β3 in man and mouse: dispersion of TGF-β gene family,” Oncogene Research, vol. 3, no. 4, pp. 323–331, 1988. View at Google Scholar · View at Scopus
  35. P. Ten Dijke, A. H. M. Geurts van Kessel, J. G. Foulkes, and M. M. Le Beau, “Transforming growth factor type β3 maps to human chromosome 14, region q23-q24,” Oncogene, vol. 3, no. 6, pp. 721–724, 1988. View at Google Scholar · View at Scopus
  36. H. Marquardt, M. N. Lioubin, and T. Ikeda, “Complete amino acid sequence of human transforming growth factor type β2,” Journal of Biological Chemistry, vol. 262, no. 25, pp. 12127–12131, 1987. View at Google Scholar · View at Scopus
  37. J. Yue and K. M. Mulder, “Transforming growth factor-β signal transduction in epithelial cells,” Pharmacology and Therapeutics, vol. 91, no. 1, pp. 1–34, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Cornelini, C. Rubini, M. Fioroni, G. A. Favero, R. Strocchi, and A. Piatteli, “Transforming growth factor-beta 1 expression in the peri-implant soft tissues of healthy and failing dental implants,” Journal of Periodontology, vol. 74, no. 4, pp. 446–450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. D. M. Kingsley, “The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms,” Genes & Development, vol. 8, no. 2, pp. 133–146, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Derynck, J. A. Jarrett, E. Y. Chen et al., “Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells,” Nature, vol. 316, no. 6030, pp. 701–705, 1985. View at Publisher · View at Google Scholar · View at Scopus
  41. L. E. Gentry and B. W. Nash, “The pro domain of pre-pro-transforming growth factor beta 1 when independently expressed is a functional binding protein for the mature growth factor,” Biochemistry, vol. 29, no. 29, pp. 6851–6857, 1990. View at Publisher · View at Google Scholar · View at Scopus
  42. L. E. Gentry, M. N. Lioubin, A. F. Purchio, and H. Marquardt, “Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor beta to the mature polypeptide,” Molecular and Cellular Biology, vol. 8, no. 10, pp. 4162–4168, 1988. View at Google Scholar · View at Scopus
  43. K. Janssens, P. Ten Dijke, S. H. Ralston, C. Bergmann, and W. van Hul, “Transforming growth factor-β1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein,” Journal of Biological Chemistry, vol. 278, no. 9, pp. 7718–7724, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. A. M. Brunner, H. Marquardt, A. R. Malacko, M. N. Lioubin, and A. F. Purchio, “Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins,” The Journal of Biological Chemistry, vol. 264, no. 23, pp. 13660–13664, 1989. View at Google Scholar · View at Scopus
  45. M. Kusakabe, P. L. Cheong, R. Nikfar, I. S. McLennan, and K. Koishi, “The structure of the TGF-β latency associated peptide region determines the ability of the proprotein convertase furin to cleave TGF-βs,” Journal of Cellular Biochemistry, vol. 103, no. 1, pp. 311–320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. C. M. Dubois, F. Blanchette, M.-H. Laprise, R. Leduc, F. Grondin, and N. G. Seidah, “Evidence that furin is an authentic transforming growth factor-β1-converting enzyme,” The American Journal of Pathology, vol. 158, no. 1, pp. 305–316, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. D. B. Rifkin, “Latent transforming growth factor-β (TGF-β) binding proteins: orchestrators of TGF-β availability,” The Journal of Biological Chemistry, vol. 280, no. 9, pp. 7409–7412, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Todorovic, V. Jurukovski, Y. Chen, L. Fontana, B. Dabovic, and D. B. Rifkin, “Latent TGF-β binding proteins,” International Journal of Biochemistry and Cell Biology, vol. 37, no. 1, pp. 38–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. H. Hayashi and T. Sakai, “Biological significance of local TGF-β activation in liver diseases,” Frontiers in Physiology, vol. 3, article 12, 2012. View at Publisher · View at Google Scholar
  50. J. Saharinen, J. Taipale, and J. Keski-Oja, “Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein LTBP-1,” The EMBO Journal, vol. 15, no. 2, pp. 245–253, 1996. View at Google Scholar · View at Scopus
  51. J. Saharinen and J. Keski-Oja, “Specific sequence motif of 8-Cys repeats of TGF-β binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β,” Molecular Biology of the Cell, vol. 11, no. 8, pp. 2691–2704, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. P.-E. Gleizes, R. C. Beavis, R. Mazzieri, B. Shen, and D. B. Rifkin, “Identification and characterization of an eight-cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor-β1,” The Journal of Biological Chemistry, vol. 271, no. 47, pp. 29891–29896, 1996. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Chen, T. Ali, V. Todorovic, J. M. O'Leary, A. Kristina Downing, and D. B. Rifkin, “Amino acid requirements for formation of the TGF-β-latent TGF-β binding protein complexes,” Journal of Molecular Biology, vol. 345, no. 1, pp. 175–186, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. K. Miyazono, A. Olofsson, P. Colosetti, and C.-H. Heldin, “A role of the latent TGF-β1-binding protein in the assembly and secretion of TGF-β1,” The EMBO Journal, vol. 10, no. 5, pp. 1091–1101, 1991. View at Google Scholar · View at Scopus
  55. K. Miyazono, J. Thyberg, and C.-H. Heldin, “Retention of the transforming growth factor-β1 precursor in the Golgi complex in a latent endoglycosidase H-sensitive form,” Journal of Biological Chemistry, vol. 267, no. 8, pp. 5668–5675, 1992. View at Google Scholar · View at Scopus
  56. S. S. Chaudhry, S. A. Cain, A. Morgan, S. L. Dallas, C. A. Shuttleworth, and C. M. Kielty, “Fibrillin-1 regulates the bioavailability of TGFβ1,” The Journal of Cell Biology, vol. 176, no. 3, pp. 355–367, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. J. Taipale, K. Miyazono, C.-H. Heldin, and J. Keski-Oja, “Latent transforming growth factor-β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein,” The Journal of Cell Biology, vol. 124, no. 1-2, pp. 171–181, 1994. View at Publisher · View at Google Scholar · View at Scopus
  58. I. Nunes, P.-E. Gleizes, C. N. Metz, and D. B. Rifkin, “Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β,” The Journal of Cell Biology, vol. 136, no. 5, pp. 1151–1163, 1997. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Unsöld, M. Hyytiäinen, L. Bruckner-Tuderman, and J. Keski-Oja, “Latent TGF-β binding protein LTBP-1 contains three potential extracellular matrix interacting domains,” Journal of Cell Science, vol. 114, no. 1, pp. 187–197, 2001. View at Google Scholar · View at Scopus
  60. Z. Isogai, R. N. Ono, S. Ushiro et al., “Latent transforming growth factor β-binding protein 1 interacts with fibrillin and is a microfibril-associated protein,” The Journal of Biological Chemistry, vol. 278, no. 4, pp. 2750–2757, 2003. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Horiguchi, M. Ota, and D. B. Rifkin, “Matrix control of transforming growth factor-β function,” Journal of Biochemistry, vol. 152, no. 4, pp. 321–329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. I. D. Campbell and M. J. Humphries, “Integrin structure, activation, and interactions,” Cold Spring Harbor Perspectives in Biology, vol. 3, no. 3, Article ID a004994, 2011. View at Publisher · View at Google Scholar
  63. J. A. Askari, P. A. Buckley, A. P. Mould, and M. J. Humphries, “Linking integrin conformation to function,” Journal of Cell Science, vol. 122, no. 2, pp. 165–170, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. J. S. Munger and D. Sheppard, “Cross talk among TGF-β signaling pathways, integrins, and the extracellular matrix,” Cold Spring Harbor perspectives in biology, vol. 3, no. 11, Article ID a005017, 2011. View at Publisher · View at Google Scholar · View at Scopus
  65. J. S. Munger, X. Huang, H. Kawakatsu et al., “The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis,” Cell, vol. 96, no. 3, pp. 319–328, 1999. View at Publisher · View at Google Scholar · View at Scopus
  66. J. P. Annes, Y. Chen, J. S. Munger, and D. B. Rifkin, “Integrin αvβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1,” The Journal of Cell Biology, vol. 165, no. 5, pp. 723–734, 2004. View at Publisher · View at Google Scholar · View at Scopus
  67. P.-J. Wipff and B. Hinz, “Integrins and the activation of latent transforming growth factor β1—an intimate relationship,” European Journal of Cell Biology, vol. 87, no. 8-9, pp. 601–615, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. Y. Sato and D. B. Rifkin, “Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-β1-like molecule by plasmin during co-culture,” The Journal of Cell Biology, vol. 109, no. 1, pp. 309–315, 1989. View at Publisher · View at Google Scholar · View at Scopus
  69. Q. Yu and I. Stamenkovic, “Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis,” Genes & Development, vol. 14, no. 2, pp. 163–176, 2000. View at Google Scholar · View at Scopus
  70. G. Ge and D. S. Greenspan, “BMP1 controls TGFβ1 activation via cleavage of latent TGFβ-binding protein,” The Journal of Cell Biology, vol. 175, no. 1, pp. 111–120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Schultz-Cherry, S. Ribeiro, L. Gentry, and J. E. Murphy-Ullrich, “Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system,” Journal of Biological Chemistry, vol. 269, no. 43, pp. 26775–26782, 1994. View at Google Scholar · View at Scopus
  72. S. Kojima, K. Nara, and D. B. Rifkin, “Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells,” The Journal of Cell Biology, vol. 121, no. 2, pp. 439–448, 1993. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Flaumenhaft, M. Abe, P. Mignatti, and D. B. Rifkin, “Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity,” The Journal of Cell Biology, vol. 118, no. 4, pp. 901–909, 1992. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Koli, M. Myllärniemi, J. Keski-Oja, and V. L. Kinnula, “Transforming growth factor-β activation in the lung: focus on fibrosis and reactive oxygen species,” Antioxidants and Redox Signaling, vol. 10, no. 2, pp. 333–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. A. P. Hinck and M. D. O'Connor-McCourt, “Structures of TGF-β receptor complexes: implications for function and therapeutic intervention using ligand traps,” Current Pharmaceutical Biotechnology, vol. 12, no. 12, pp. 2081–2098, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. S. Cheifetz, A. Bassols, K. Stanley, M. Ohta, J. Greenberger, and J. Massagué, “Heterodimeric transforming growth factor β. Biological properties and interaction with three types of cell surface receptors,” The Journal of Biological Chemistry, vol. 263, no. 22, pp. 10783–10789, 1988. View at Google Scholar · View at Scopus
  77. F. T. Boyd, S. Cheifetz, J. Andres, M. Laiho, and J. Massagué, “Transforming growth factor-beta receptors and binding proteoglycans,” Journal of Cell Science. Supplement, vol. 13, pp. 131–138, 1990. View at Google Scholar · View at Scopus
  78. T. Huang, L. David, V. Mendoza et al., “TGF-β signalling is mediated by two autonomously functioning TβRI:TβRII pairs,” The EMBO Journal, vol. 30, no. 7, pp. 1263–1276, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Okadome, H. Yamashita, P. Franzén, A. Morén, C.-H. Heldin, and K. Miyazono, “Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction,” The Journal of Biological Chemistry, vol. 269, no. 49, pp. 30753–30756, 1994. View at Google Scholar · View at Scopus
  80. A. P. Hinck, “Structural studies of the TGF-βs and their receptors—insights into evolution of the TGF-β superfamily,” FEBS Letters, vol. 586, no. 14, pp. 1860–1870, 2012. View at Publisher · View at Google Scholar · View at Scopus
  81. B. Pasche, Y. Luo, P. H. Rao et al., “Type I transforming growth factor β receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract,” Cancer Research, vol. 58, no. 13, pp. 2727–2732, 1998. View at Google Scholar · View at Scopus
  82. F. T. Boyd and J. Massagué, “Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor,” The Journal of Biological Chemistry, vol. 264, no. 4, pp. 2272–2278, 1989. View at Google Scholar · View at Scopus
  83. K. E. Shapira, A. Gross, M. Ehrlich, and Y. I. Henis, “Coated pit-mediated endocytosis of the type I Transforming Growth Factor-β (TGF-β) receptor depends on a Di-leucine family signal and is not required for signaling,” The Journal of Biological Chemistry, vol. 287, no. 32, pp. 26876–26889, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. P. Franzén, P. ten Dijke, H. Ichijo et al., “Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor,” Cell, vol. 75, no. 4, pp. 681–692, 1993. View at Publisher · View at Google Scholar · View at Scopus
  85. P. Franzén, C. H. Heldin, and K. Miyazono, “The GS domain of the transformining growth factor-β type I receptor is important in signal transduction,” Biochemical and Biophysical Research Communications, vol. 207, no. 2, pp. 682–689, 1995. View at Publisher · View at Google Scholar · View at Scopus
  86. H. Y. Lin, X.-F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish, “Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase,” Cell, vol. 68, no. 4, pp. 775–785, 1992. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Mathew, V. V. V. S. Murty, S. Cheifetz, D. George, J. Massague, and R. S. K. Chaganti, “Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22,” Genomics, vol. 20, no. 1, pp. 114–115, 1994. View at Publisher · View at Google Scholar · View at Scopus
  88. H. Liu, X. Wang, C. Wang et al., “Molecular cloning, in vitro expression and bioactivity of rabbit transforming growth factor-beta receptor type II (rTGF-βRII),” Veterinary Immunology and Immunopathology, vol. 140, no. 1-2, pp. 55–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. K. Tsuchida, K. A. Lewis, L. S. Mathews, and W. W. Vale, “Molecular characterization of rat transforming growth factor-β type II receptor,” Biochemical and Biophysical Research Communications, vol. 191, no. 3, pp. 790–795, 1993. View at Publisher · View at Google Scholar · View at Scopus
  90. J. L. Wrana, L. Attisano, J. Cárcamo et al., “TGF beta signals through a heteromeric protein kinase receptor complex,” Cell, vol. 71, no. 6, pp. 1003–1014, 1992. View at Google Scholar
  91. J. L. Wrana, L. Attisano, R. Wieser, F. Ventura, and J. Massagué, “Mechanism of activation of the TGF-β receptor,” Nature, vol. 370, no. 6488, pp. 341–347, 1994. View at Publisher · View at Google Scholar · View at Scopus
  92. M. Saitoh, H. Nishitoh, T. Amagasa, K. Miyazono, M. Takagi, and H. Ichijo, “Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-β,” The Journal of Biological Chemistry, vol. 271, no. 5, pp. 2769–2775, 1996. View at Publisher · View at Google Scholar · View at Scopus
  93. K. Luo and H. F. Lodish, “Positive and negative regulation of type II TGF-β receptor signal transduction by autophosphorylation on multiple serine residues,” The EMBO Journal, vol. 16, no. 8, pp. 1970–1981, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. S. Cheifetz, J. L. Andres, and J. Massagué, “The transforming growth factor-β receptor type III is a membrane proteoglycan. Domain structure of the receptor,” The Journal of Biological Chemistry, vol. 263, no. 32, pp. 16984–16991, 1988. View at Google Scholar · View at Scopus
  95. F. López-Casillas, H. M. Payne, J. L. Andres, and J. Massagué, “Betaglycan can act as a dual modulator of TGF-β access to signaling receptors: mapping of ligand binding and GAG attachment sites,” Journal of Cell Biology, vol. 124, no. 4, pp. 557–568, 1994. View at Publisher · View at Google Scholar · View at Scopus
  96. C. Bernabeu, J. M. Lopez-Novoa, and M. Quintanilla, “The emerging role of TGF-β superfamily coreceptors in cancer,” Biochimica et Biophysica Acta, vol. 1792, no. 10, pp. 954–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. J. Esparza-López, J. L. Montiel, M. M. Vilchis-Landeros, T. Okadome, K. Miyazono, and F. López-Casillas, “Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-β superfamily. Specialized binding regions for transforming growth factor-β and inhibin A,” The Journal of Biological Chemistry, vol. 276, no. 18, pp. 14588–14596, 2001. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Bilandzic and K. L. Stenvers, “Betaglycan: a multifunctional accessory,” Molecular and Cellular Endocrinology, vol. 339, no. 1-2, pp. 180–189, 2011. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Nassiri, M. D. Cusimano, B. W. Scheithauer et al., “Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy,” Anticancer Research, vol. 31, no. 6, pp. 2283–2290, 2011. View at Google Scholar · View at Scopus
  100. S. Cheifetz, T. Bellón, C. Calés et al., “Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells,” The Journal of Biological Chemistry, vol. 267, no. 27, pp. 19027–19030, 1992. View at Google Scholar · View at Scopus
  101. H. Yamashita, H. Ichijo, S. Grimsby, A. Morén, P. Ten Dijke, and K. Miyazono, “Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β,” The Journal of Biological Chemistry, vol. 269, no. 3, pp. 1995–2001, 1994. View at Google Scholar · View at Scopus
  102. E. J. Mitchell, L. Fitz-Gibbon, and M. D. O'Connor-McCourt, “Subtypes of betaglycan and of Type I and Type II transforming growth actor-β (TGF-β) receptors with different affinities for TGF-β1 and TGF-β2 are exhibited by human placental trophoblast cells,” Journal of Cellular Physiology, vol. 150, no. 2, pp. 334–343, 1992. View at Publisher · View at Google Scholar · View at Scopus
  103. P. Lönn, A. Morén, E. Raja, M. Dahl, and A. Moustakas, “Regulating the stability of TGFβ receptors and Smads,” Cell Research, vol. 19, no. 1, pp. 21–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  104. S. Itoh, M. Landström, A. Hermansson et al., “Transforming growth factor β1 induces nuclear export of inhibitory Smad7,” Journal of Biological Chemistry, vol. 273, no. 44, pp. 29195–29201, 1998. View at Publisher · View at Google Scholar · View at Scopus
  105. T. Ebisawa, M. Fukuchi, G. Murakami et al., “Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation,” The Journal of Biological Chemistry, vol. 276, no. 16, pp. 12477–12480, 2001. View at Publisher · View at Google Scholar · View at Scopus
  106. P. Kavsak, R. K. Rasmussen, C. G. Causing et al., “Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation,” Molecular Cell, vol. 6, no. 6, pp. 1365–1375, 2000. View at Publisher · View at Google Scholar · View at Scopus
  107. X. Hao, Y. Wang, F. Ren et al., “SNX25 regulates TGF-β signaling by enhancing the receptor degradation,” Cellular Signalling, vol. 23, no. 5, pp. 935–946, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. Y. G. Chen, “Endocytic regulation of TGF-beta signaling,” Cell Research, vol. 19, no. 1, pp. 58–70, 2009. View at Publisher · View at Google Scholar
  109. C. le Roy and J. L. Wrana, “Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling,” Nature Reviews Molecular Cell Biology, vol. 6, no. 2, pp. 112–126, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. G. M. Di Guglielmo, C. Le Roy, A. F. Goodfellow, and J. L. Wrana, “Distinct endocytic pathways regulate TGF-β receptor signalling and turnover,” Nature Cell Biology, vol. 5, no. 5, pp. 410–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  111. G. J. Inman, “Linking Smads and transcriptional activation,” The Biochemical Journal, vol. 386, no. 1, pp. e1–e3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Weiss and L. Attisano, “The TGFbeta superfamily signaling pathway,” Wiley Interdisciplinary Reviews: Developmental Biology, vol. 2, no. 1, pp. 47–63, 2013. View at Publisher · View at Google Scholar
  113. A. Moustakas and C.-H. Heldin, “The regulation of TGFβ signal transduction,” Development, vol. 136, no. 22, pp. 3699–3714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. P. Makkar, R. P. R. Metpally, S. Sangadala, and B. V. B. Reddy, “Modeling and analysis of MH1 domain of Smads and their interaction with promoter DNA sequence motif,” Journal of Molecular Graphics and Modelling, vol. 27, no. 7, pp. 803–812, 2009. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Massagué, J. Seoane, and D. Wotton, “Smad transcription factors,” Genes & Development, vol. 19, no. 23, pp. 2783–2810, 2005. View at Publisher · View at Google Scholar · View at Scopus
  116. K. Tada, H. Inoue, T. Ebisawa et al., “Region between α-helices 3 and 4 of the Mad homology 2 domain of Smad4: functional roles in oligomer formation and transcriptional activation,” Genes to Cells, vol. 4, no. 12, pp. 731–741, 1999. View at Publisher · View at Google Scholar · View at Scopus
  117. J. Massagué, “TGF β signalling in context,” Nature Reviews Molecular Cell Biology, vol. 13, no. 10, pp. 616–630, 2012. View at Publisher · View at Google Scholar
  118. F. Itoh, N. Divecha, L. Brocks et al., “The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signalling,” Genes to Cells, vol. 7, no. 3, pp. 321–331, 2002. View at Publisher · View at Google Scholar · View at Scopus
  119. Z. Xiao, X. Liu, Y. I. Henis, and H. F. Lodish, “A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 14, pp. 7853–7858, 2000. View at Publisher · View at Google Scholar · View at Scopus
  120. Z. Xiao, X. Liu, and H. F. Lodish, “Importin β mediates nuclear translocation of Smad 3,” Journal of Biological Chemistry, vol. 275, no. 31, pp. 23425–23428, 2000. View at Publisher · View at Google Scholar · View at Scopus
  121. G. J. Inman, F. J. Nicolás, and C. S. Hill, “Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity,” Molecular Cell, vol. 10, no. 2, pp. 283–294, 2002. View at Publisher · View at Google Scholar · View at Scopus
  122. Y. Li, M. Wang, C. Carra, and F. A. Cucinotta, “Modularized Smad-regulated TGFβ signaling pathway,” Mathematical Biosciences, vol. 240, no. 2, pp. 187–200, 2012. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  123. A. Hanyu, Y. Ishidou, T. Ebisawa, T. Shimanuki, T. Imamura, and K. Miyazono, “The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling,” The Journal of Cell Biology, vol. 155, no. 6, pp. 1017–1027, 2001. View at Publisher · View at Google Scholar · View at Scopus
  124. C. Suzuki, G. Murakami, M. Fukuchi et al., “Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane,” The Journal of Biological Chemistry, vol. 277, no. 42, pp. 39919–39925, 2002. View at Publisher · View at Google Scholar · View at Scopus
  125. A. Moustakas and C. H. Heldin, “Non-Smad TGF-β signals,” Journal of Cell Science, vol. 118, no. 16, pp. 3573–3584, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. D. Horbelt, A. Denkis, and P. Knaus, “A portrait of Transforming Growth Factor β superfamily signalling: background matters,” International Journal of Biochemistry and Cell Biology, vol. 44, no. 3, pp. 469–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  127. A. V. Bakin, C. Rinehart, A. K. Tomlinson, and C. L. Arteaga, “p38 mitogen-activated protein kinase is required for TGFβ-mediated fibroblastic transdifferentiation and cell migration,” Journal of Cell Science, vol. 115, no. 15, pp. 3193–3206, 2002. View at Google Scholar · View at Scopus
  128. D. A. Chapnick, L. Warner, J. Bernet, T. Rao, and X. Liu, “Partners in crime: The TGFβ and MAPK pathways in cancer progression,” Cell and Bioscience, vol. 1, no. 1, article 42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. Y. Cha, D.-K. Kim, J. Hyun, S.-J. Kim, and K.-S. Park, “TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells,” Cellular Signalling, vol. 25, no. 5, pp. 1245–1251, 2013. View at Publisher · View at Google Scholar · View at Scopus
  130. D. Javelaud and A. Mauviel, “Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis,” Oncogene, vol. 24, no. 37, pp. 5742–5750, 2005. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Hong, M. C. Wilkes, S. G. Penheiter, S. K. Gupta, M. Edens, and E. B. Leof, “Non-Smad transforming growth factor-β signaling regulated by focal adhesion kinase binding the p85 subunit of phosphatidylinositol 3-kinase,” Journal of Biological Chemistry, vol. 286, no. 20, pp. 17841–17850, 2011. View at Publisher · View at Google Scholar · View at Scopus
  132. S. Lamouille, E. Connolly, J. W. Smyth, R. J. Akhurst, and R. Derynck, “TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion,” Journal of Cell Science, vol. 125, part 5, pp. 1259–1273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  133. A. Gingery, E. W. Bradley, L. Pederson, M. Ruan, N. J. Horwood, and M. J. Oursler, “TGF-β coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival,” Experimental Cell Research, vol. 314, no. 15, pp. 2725–2738, 2008. View at Publisher · View at Google Scholar · View at Scopus
  134. J. Zhu, D. Nguyen, O. Hong, X.-H. Zhang, X.-M. Chen, and K. Zhang, “Inhibition of RhoA/Rho-kinase pathway suppresses the expression of extracellular matrix induced by CTGF or TGF-β in ARPE-19,” International Journal of Ophthalmology, vol. 6, no. 1, pp. 8–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  135. N. Rucci, “Molecular biology of bone remodelling,” Clinical Cases in Mineral and Bone Metabolism, vol. 5, no. 1, pp. 49–56, 2008. View at Google Scholar · View at Scopus
  136. G. Mori, P. D'Amelio, R. Faccio, and G. Brunetti, “The interplay between the bone and the immune system,” Clinical and Developmental Immunology, vol. 2013, Article ID 720504, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. L. C. Gerstenfeld, D. M. Cullinane, G. L. Barnes, D. T. Graves, and T. A. Einhorn, “Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation,” Journal of Cellular Biochemistry, vol. 88, no. 5, pp. 873–884, 2003. View at Publisher · View at Google Scholar · View at Scopus
  138. M. M. Sandberg, H. T. Aro, and E. I. Vuorio, “Gene expression during bone repair,” Clinical Orthopaedics and Related Research, no. 289, pp. 292–312, 1993. View at Google Scholar · View at Scopus
  139. C. H. Rundle, H. Wang, H. Yu et al., “Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair,” Bone, vol. 38, no. 4, pp. 521–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. A. Schindeler, M. M. McDonald, P. Bokko, and D. G. Little, “Bone remodeling during fracture repair: the cellular picture,” Seminars in Cell and Developmental Biology, vol. 19, no. 5, pp. 459–466, 2008. View at Publisher · View at Google Scholar · View at Scopus
  141. T. A. Einhorn and L. C. Gerstenfeld, “Fracture healing: mechanisms and interventions,” Nature Reviews Rheumatology, 2014. View at Publisher · View at Google Scholar
  142. P. V. Giannoudis, H. B. Tan, S. Perry, C. Tzioupis, and N. K. Kanakaris, “The systemic inflammatory response following femoral canal reaming using the reamer-irrigator-aspirator (RIA) device,” Injury, vol. 41, no. 2, pp. S57–S61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  143. L. Claes, S. Recknagel, and A. Ignatius, “Fracture healing under healthy and inflammatory conditions,” Nature Reviews Rheumatology, vol. 8, no. 3, pp. 133–143, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. L. Marzona and B. Pavolini, “Play and players in bone fracture healing match,” Clinical Cases in Mineral and Bone Metabolism, vol. 6, no. 2, pp. 159–162, 2009. View at Google Scholar · View at Scopus
  145. D. E. Komatsu and S. J. Warden, “The control of fracture healing and its therapeutic targeting: improving upon nature,” Journal of Cellular Biochemistry, vol. 109, no. 2, pp. 302–311, 2010. View at Publisher · View at Google Scholar
  146. N. C. Keramaris, G. M. Calori, V. S. Nikolaou, E. H. Schemitsch, and P. V. Giannoudis, “Fracture vascularity and bone healing: a systematic review of the role of VEGF,” Injury, vol. 39, supplement 2, pp. S45–S57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Graham, A. Leonidou, M. Lester, M. Heliotis, A. Mantalaris, and E. Tsiridis, “Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing,” Expert Opinion on Investigational Drugs, vol. 18, no. 11, pp. 1633–1654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  148. G. Schmidmaier, B. Wildemann, J. Heeger et al., “Improvement of fracture healing by systemic administration of growth hormone and local application of insulin-like growth factor-1 and transforming growth factor-β1,” Bone, vol. 31, no. 1, pp. 165–172, 2002. View at Publisher · View at Google Scholar · View at Scopus
  149. A. S. Patil, R. B. Sable, and R. M. Kothari, “An update on transforming growth factor-β (TGF-β): sources, types, functions and clinical applicability for cartilage/bone healing,” Journal of Cellular Physiology, vol. 226, no. 12, pp. 3094–3103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  150. A. M. Phillips, “Overview of the fracture healing cascade,” Injury, vol. 36, supplement 3, pp. S5–S7, 2005. View at Google Scholar · View at Scopus
  151. R. E. Marx, E. R. Carlson, R. M. Eichstaedt, S. R. Schimmele, J. E. Strauss, and K. R. Georgeff, “Platelet-rich plasma: growth factor enhancement for bone grafts,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, vol. 85, no. 6, pp. 638–646, 1998. View at Publisher · View at Google Scholar · View at Scopus
  152. M. E. Joyce, R. M. Terek, S. Jingushi, and M. E. Bolander, “Role of transforming growth factor-β in fracture repair,” Annals of the New York Academy of Sciences, vol. 593, pp. 107–123, 1990. View at Publisher · View at Google Scholar · View at Scopus
  153. W. T. Bourque, M. Gross, and B. K. Hall, “Expression of four growth factors during fracture repair,” International Journal of Developmental Biology, vol. 37, no. 4, pp. 573–579, 1993. View at Google Scholar · View at Scopus
  154. K. Matsumoto, S. Matsunaga, T. Imamura, Y. Ishidou, H. Yoshida, and T. Sakou, “Expression and distribution of transforming growth factor-β and decorin during fracture healing,” In Vivo, vol. 8, no. 2, pp. 215–220, 1994. View at Google Scholar · View at Scopus
  155. X. Si, Y. Jin, L. Yang, G. L. Tipoe, and F. H. White, “Expression of BMP-2 and TGF-β1 mRNA during healing of the rabbit mandible,” European Journal of Oral Sciences, vol. 105, no. 4, pp. 325–330, 1997. View at Publisher · View at Google Scholar · View at Scopus
  156. T.-J. Cho, L. C. Gerstenfeld, and T. A. Einhorn, “Differential temporal expression of members of the transforming growth factor β superfamily during murine fracture healing,” Journal of Bone and Mineral Research, vol. 17, no. 3, pp. 513–520, 2002. View at Publisher · View at Google Scholar · View at Scopus
  157. R. A. Meyer Jr., M. H. Meyer, M. Tenholder, S. Wondracek, R. Wasserman, and P. Garges, “Gene expression in older rats with delayed union of femoral fractures,” Journal of Bone and Joint Surgery—Series A, vol. 85, no. 7, pp. 1243–1254, 2003. View at Google Scholar · View at Scopus
  158. B. Wildemann, G. Schmidmaier, N. Brenner et al., “Quantification, localization, and expression of IGF-I and TGF-β1 during growth factor-stimulated fracture healing,” Calcified Tissue International, vol. 74, no. 4, pp. 388–397, 2004. View at Publisher · View at Google Scholar · View at Scopus
  159. J. G. Andrew, J. Hoyland, S. M. Andrew, A. J. Freemont, and D. Marsh, “Demonstration of TGF-β1 mRNA by in situ hybridization in normal human fracture healing,” Calcified Tissue International, vol. 52, no. 2, pp. 74–78, 1993. View at Publisher · View at Google Scholar · View at Scopus
  160. Y. Yu, J. L. Yang, P. J. Chapman-Sheath, and W. R. Walsh, “TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing,” Journal of Biomedical Materials Research, vol. 60, no. 3, pp. 392–397, 2002. View at Publisher · View at Google Scholar
  161. T. Sakou, T. Onishi, T. Yamamoto, T. Nagamine, T. K. Sampath, and P. Ten Dijke, “Localization of Smads, the TGF-β family intracellular signaling components during endochondral ossification,” Journal of Bone and Mineral Research, vol. 14, no. 7, pp. 1145–1152, 1999. View at Publisher · View at Google Scholar · View at Scopus
  162. G. Zimmermann, P. Henle, M. Küsswetter et al., “TGF-β1 as a marker of delayed fracture healing,” Bone, vol. 36, no. 5, pp. 779–785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  163. G. Zimmermann, A. Moghaddam, M. Reumann et al., “TGF-β1 as a pathophysiological factor in fracture healing,” Unfallchirurg, vol. 110, no. 2, pp. 130–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  164. A. Moghaddam, S. Weiss, C. G. Wölfl et al., “Cigarette smoking decreases TGF-β1 serum concentrations after long bone fracture,” Injury, vol. 41, no. 10, pp. 1020–1025, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. R. C. Castillo, M. J. Bosse, E. J. MacKenzie et al., “Impact of smoking on fracture healing and risk of complications in limb-threatening open tibia fractures,” Journal of Orthopaedic Trauma, vol. 19, no. 3, pp. 151–157, 2005. View at Publisher · View at Google Scholar · View at Scopus
  166. G. Kaiser, A. Thomas, J. Köttstorfer, M. Kecht, and K. Sarahrudi, “Is the expression of transforming growth factor-beta1 after fracture of long bones solely influenced by the healing process?” International Orthopaedics, vol. 36, no. 10, pp. 2173–2179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  167. H. Li, C.-Z. Liang, Y.-Q. Tao, C.-C. Shen, and Q.-X. Chen, “Elevated local TGF-β1 level predisposes a closed bone fracture to tuberculosis infection,” Medical Hypotheses, vol. 79, no. 3, pp. 400–402, 2012. View at Publisher · View at Google Scholar · View at Scopus
  168. G. Chen, C. Deng, and Y. P. Li, “TGF-β and BMP signaling in osteoblast differentiation and bone formation,” International Journal of Biological Sciences, vol. 8, no. 2, pp. 272–288, 2012. View at Publisher · View at Google Scholar
  169. S. M. Seyedin, T. C. Thomas, A. Y. Thompson, D. M. Rosen, and K. A. Piez, “Purification and characterization of two cartilage-inducing factors from bovine demineralized bone,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 8, pp. 2267–2271, 1985. View at Publisher · View at Google Scholar · View at Scopus
  170. R. K. Assoian, A. Komoriya, C. A. Meyers, D. M. Miller, and M. B. Sporn, “Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization,” The Journal of Biological Chemistry, vol. 258, no. 11, pp. 7155–7160, 1983. View at Google Scholar · View at Scopus
  171. O. Wahlström, C. Linder, A. Kalén, and P. Magnusson, “Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells,” Platelets, vol. 18, no. 2, pp. 113–118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  172. O. Wahlström, C. Linder, A. Kalén, and P. Magnusson, “Acidic preparations of platelet concentrates release bone morphogenetic protein-2,” Acta Orthopaedica, vol. 79, no. 3, pp. 433–437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  173. F. J. Hughes, J. E. Aubin, and J. N. M. Heersche, “Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor β,” Bone and Mineral, vol. 19, no. 1, pp. 63–74, 1992. View at Publisher · View at Google Scholar · View at Scopus
  174. F. Celotti, A. Colciago, P. Negri-Cesi, A. Pravettoni, R. Zaninetti, and M. C. Sacchi, “Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: role of platelet-derived growth factor and transforming growth factor-β,” Wound Repair and Regeneration, vol. 14, no. 2, pp. 195–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  175. J. S. Kim, J. G. Kim, M. Y. Moon et al., “Transforming growth factor-β1 regulates macrophage migration via RhoA,” Blood, vol. 108, no. 6, pp. 1821–1829, 2006. View at Publisher · View at Google Scholar · View at Scopus
  176. A. Mendelson, E. Frank, C. Allred et al., “Chondrogenesis by chemotactic homing of synovium, bone marrow, and adipose stem cells in vitro,” The FASEB Journal, vol. 25, no. 10, pp. 3496–3504, 2011. View at Publisher · View at Google Scholar · View at Scopus
  177. K. Narine, O. De Wever, D. Van Valckenborgh et al., “Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering,” Tissue Engineering, vol. 12, no. 10, pp. 2707–2716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  178. C. Chenu, J. Pfeilschifter, G. R. Mundy, and G. D. Roodman, “Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 15, pp. 5683–5687, 1988. View at Publisher · View at Google Scholar · View at Scopus
  179. J. Pfeilschifter, S. M. Seyedin, and G. R. Mundy, “Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures,” The Journal of Clinical Investigation, vol. 82, no. 2, pp. 680–685, 1988. View at Publisher · View at Google Scholar · View at Scopus
  180. A. Erlebacher, E. H. Filvaroff, J.-Q. Ye, and R. Derynck, “Osteoblastic responses to TGF-β during bone remodeling,” Molecular Biology of the Cell, vol. 9, no. 7, pp. 1903–1918, 1998. View at Publisher · View at Google Scholar · View at Scopus
  181. G. R. Mundy, “Regulation of bone formation by bone morphogenetic proteins and other growth factors,” Clinical Orthopaedics and Related Research, no. 324, pp. 24–28, 1996. View at Google Scholar · View at Scopus
  182. T.-F. Li, R. J. O'Keefe, and D. Chen, “TGF-beta signaling in chondrocytes,” Frontiers in Bioscience, vol. 10, pp. 681–688, 2005. View at Publisher · View at Google Scholar · View at Scopus
  183. L. F. Bonewald and S. L. Dallas, “Role of active and latent transforming growth Factor β in bone formation,” Journal of Cellular Biochemistry, vol. 55, no. 3, pp. 350–357, 1994. View at Publisher · View at Google Scholar · View at Scopus
  184. M. Centrella, M. C. Horowitz, J. M. Wozney, and T. L. Mccarthy, “Transforming growth factor-β gene family members and bone,” Endocrine Reviews, vol. 15, no. 1, pp. 27–39, 1994. View at Publisher · View at Google Scholar · View at Scopus
  185. M. Noda, “Transcriptional regulation of osteocalcin production by transforming growth factor-β in rat osteoblast-like cells,” Endocrinology, vol. 124, no. 2, pp. 612–617, 1989. View at Publisher · View at Google Scholar · View at Scopus
  186. J. Massagué, “The transforming growth factor-beta family,” Annual Review of Cell Biology, vol. 6, pp. 597–641, 1990. View at Google Scholar
  187. P. B. Saadeh, B. J. Mehrara, D. S. Steinbrech et al., “Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts,” American Journal of Physiology, vol. 277, no. 4, part 1, pp. C628–C637, 1999. View at Google Scholar · View at Scopus
  188. C. C. Chua, R. C. Hamdy, and B. H. L. Chua, “Mechanism of transforming growth factor-β1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells,” Biochimica et Biophysica Act—Molecular Cell Research, vol. 1497, no. 1, pp. 69–76, 2000. View at Publisher · View at Google Scholar · View at Scopus
  189. Y. Yamada, T. Tamura, K. Hariu, Y. Asano, S. Sato, and K. Ito, “Angiogenesis in newly augmented bone observed in rabbit calvarium using a titanium cap,” Clinical Oral Implants Research, vol. 19, no. 10, pp. 1003–1009, 2008. View at Publisher · View at Google Scholar · View at Scopus
  190. M. L. Brandi and P. Collin-Osdoby, “Vascular biology and the skeleton,” Journal of Bone and Mineral Research, vol. 21, no. 2, pp. 183–192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  191. P. Madeddu, “Therapeutic angiogenesis and vasculogenesis for tissue regeneration,” Experimental Physiology, vol. 90, no. 3, pp. 315–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  192. V. V. Orlova, Z. Liu, M.-J. Goumans, and P. ten Dijke, “Controlling angiogenesis by two unique TGF-β type I receptor signaling pathways,” Histology and Histopathology, vol. 26, no. 9, pp. 1219–1230, 2011. View at Google Scholar · View at Scopus
  193. G. Ferrari, B. D. Cook, V. Terushkin, G. Pintucci, and P. Mignatti, “Transforming growth factor-beta 1 (TGF-β1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis,” Journal of Cellular Physiology, vol. 219, no. 2, pp. 449–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  194. M. T. Coconi, B. Nico, P. Rebuffat et al., “Angiogenic response induced by acellular femoral matrix in vivo,” Journal of Anatomy, vol. 207, no. 1, pp. 79–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  195. M. E. Joyce, A. B. Roberts, M. B. Sporn, and M. E. Bolander, “Transforming growth factor-β and the initiation of chondrogenesis and osteogenesis in the rat femur,” Journal of Cell Biology, vol. 110, no. 6, pp. 2195–2207, 1990. View at Publisher · View at Google Scholar · View at Scopus
  196. Y. Sun, Y. Lu, Y. Hu, F. Ma, and W. Chen, “Induction of osteogenesis by bovine platelet transforming growth factor-beta (TGF-β) in adult mouse femur,” Chinese Medical Journal, vol. 108, no. 12, pp. 914–918, 1995. View at Google Scholar · View at Scopus
  197. L. S. Beck, E. P. Amento, Y. Xu et al., “TGF-β1 induces bone closure of skull defects: temporal dynamics of bone formation in defects exposed to rhTGF-β1,” Journal of Bone and Mineral Research, vol. 8, no. 6, pp. 753–761, 1993. View at Google Scholar · View at Scopus
  198. M. Lind, B. Schumacker, K. Søballe, J. Keller, F. Melsen, and C. Bünger, “Transforming growth factor-β enhances fracture healing in rabbit tibiae,” Acta Orthopaedica Scandinavica, vol. 64, no. 5, pp. 553–556, 1993. View at Publisher · View at Google Scholar · View at Scopus
  199. H. M. Nielsen, T. T. Andreassen, T. Ledet, and H. Oxlund, “Local injection of TGF-β increases the strength of tibial fractures in the rat,” Acta Orthopaedica Scandinavica, vol. 65, no. 1, pp. 37–41, 1994. View at Publisher · View at Google Scholar · View at Scopus
  200. M. A. Critchlow, Y. S. Bland, and D. E. Ashhurst, “The effect of exogenous transforming growth factor-β2 on healing fractures in the rabbit,” Bone, vol. 16, no. 5, pp. 521–527, 1995. View at Publisher · View at Google Scholar · View at Scopus
  201. J. D. Heckman, W. Ehler, B. P. Brooks et al., “Bone morphogenetic protein but not transforming growth factor-β enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer,” Journal of Bone and Joint Surgery, Series A, vol. 81, no. 12, pp. 1717–1729, 1999. View at Google Scholar · View at Scopus
  202. G. Schmidmaier, M. Lucke, P. Schwabe, M. Raschke, N. P. Haas, and B. Wildemann, “Collective review: bioactive implants coated with poly(D,L-lactide) and growth factors IGF-I, TGF-β1, or BMP-2 for stimulation of fracture healing,” Journal of Long-Term Effects of Medical Implants, vol. 16, no. 1, pp. 61–69, 2006. View at Publisher · View at Google Scholar · View at Scopus
  203. G. Schmidmaier, B. Wildemann, T. Gäbelein et al., “Synergistic effect of IGF-I and TGF-β1 on fracture healing in rats: single versus combined application of IGF-I and TGF-β1,” Acta Orthopaedica Scandinavica, vol. 74, no. 5, pp. 604–610, 2003. View at Publisher · View at Google Scholar · View at Scopus
  204. G. Schmidmaier, B. Wildemann, M. Lübberstedt, N. P. Haas, and M. Raschke, “IGF-I and TGF-beta 1 incorporated in a poly(D,L-lactide) implant coating stimulates osteoblast differentiation and collagen-1 production but reduces osteoblast proliferation in cell culture,” Journal of Biomedical Materials Research Part B Applied Biomaterials, vol. 65, no. 1, pp. 157–162, 2003. View at Google Scholar · View at Scopus
  205. A. Bernstein, H. O. Mayr, and R. Hube, “Can bone healing in distraction osteogenesis be accelerated by local application of IGF-1 and TGF-beta1?” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 92, no. 1, pp. 215–225, 2010. View at Publisher · View at Google Scholar
  206. S. Srouji, A. Rachmiel, I. Blumenfeld, and E. Livne, “Mandibular defect repair by TGF-β and IGF-1 released from a biodegradable osteoconductive hydrogel,” Journal of Cranio-Maxillofacial Surgery, vol. 33, no. 2, pp. 79–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  207. A. Lamberg, G. Schmidmaier, K. Søballe, and B. Elmengaard, “Locally delivered TGF-β1 and IGF-1 enhance the fixation of titanium implants: a study in dogs,” Acta Orthopaedica, vol. 77, no. 5, pp. 799–805, 2006. View at Publisher · View at Google Scholar · View at Scopus
  208. T. T. Gui, J. Pagkalos, E. Tsiridis, A. A. Narvani, M. Heliotis, and A. Mantalaris, “Growth hormone: does it have a therapeutic role in fracture healing?” Expert Opinion on Investigational Drugs, vol. 18, no. 7, pp. 887–911, 2009. View at Publisher · View at Google Scholar · View at Scopus
  209. T. J. Myers, Y. Yan, F. Granero-Molto et al., “Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing,” Growth Factors, vol. 30, no. 4, pp. 230–241, 2012. View at Publisher · View at Google Scholar
  210. X. L. Griffin, C. M. Smith, and M. L. Costa, “The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review,” Injury, vol. 40, no. 2, pp. 158–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  211. X. L. Griffin, D. Wallace, N. Parsons, and M. L. Costa, “Platelet rich therapies for long bone healing in adults,” Cochrane Database of Systematic Reviews, vol. 7, Article ID CD009496, 2012. View at Google Scholar · View at Scopus
  212. M. Lenza, S. de Barros Ferraz, D. C. M. Viola, O. F. P. dos Santos, M. C. Neto, and M. Ferretti, “Platelet-rich plasma for long bone healing,” Einstein, vol. 11, no. 1, pp. 122–127, 2013. View at Publisher · View at Google Scholar · View at Scopus
  213. R. S. Dhillon, E. M. Schwarz, and M. D. Maloney, “Platelet-rich plasma therapy—future or trend?” Arthritis Research & Therapy, vol. 14, no. 4, p. 219, 2012. View at Publisher · View at Google Scholar
  214. D. Dallari, L. Savarino, C. Stagni et al., “Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells,” Journal of Bone and Joint Surgery A, vol. 89, no. 11, pp. 2413–2420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  215. J. C. Peerbooms, J. W. Colaris, A. A. Hakkert et al., “No positive bone healing after using platelet rich plasma in a skeletal defect. An observational prospective cohort study,” International Orthopaedics, vol. 36, no. 10, pp. 2113–2119, 2012. View at Publisher · View at Google Scholar · View at Scopus
  216. H. Kitoh, T. Kitakoji, H. Tsuchiya, M. Katoh, and N. Ishiguro, “Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones,” Bone, vol. 40, no. 2, pp. 522–528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  217. H. Kitoh, T. Kitakoji, H. Tsuchiya, M. Katoh, and N. Ishiguro, “Distraction osteogenesis of the lower extremity in patients with achondroplasia/hypochondroplasia treated with transplantation of culture-expanded bone marrow cells and platelet-rich plasma,” Journal of Pediatric Orthopaedics, vol. 27, no. 6, pp. 629–634, 2007. View at Publisher · View at Google Scholar · View at Scopus
  218. L. Y. Carreon, S. D. Glassman, Y. Anekstein, and R. M. Puno, “Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusions,” Spine, vol. 30, no. 9, pp. E243–E247, 2005. View at Publisher · View at Google Scholar · View at Scopus
  219. G. M. Calori, M. D'Avino, L. Tagliabue, W. Albisetti, M. d'Imporzano, and G. Peretti, “An ongoing research for evaluation of treatment with BMPs or AGFs in long bone non-union: protocol description and preliminary results,” Injury, vol. 37, supplement 3, pp. S43–S50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  220. C. Bibbo, C. M. Bono, and S. S. Lin, “Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients,” Journal of Surgical Orthopaedic Advances, vol. 14, no. 1, pp. 17–22, 2005. View at Google Scholar · View at Scopus
  221. C.-L. Shen, I.-S. Kwun, S. Wang et al., “Functions and mechanisms of green tea catechins in regulating bone remodeling,” Current Drug Targets, vol. 14, no. 13, pp. 1619–1630, 2013. View at Publisher · View at Google Scholar · View at Scopus
  222. J. A. Kanis, E. V. McCloskey, H. Johansson, and A. Oden, “Approaches to the targeting of treatment for osteoporosis,” Nature reviews. Rheumatology, vol. 5, no. 8, pp. 425–431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  223. V. S. Nikolaou, N. Efstathopoulos, G. Kontakis, N. K. Kanakaris, and P. V. Giannoudis, “The influence of osteoporosis in femoral fracture healing time,” Injury, vol. 40, no. 6, pp. 663–668, 2009. View at Publisher · View at Google Scholar · View at Scopus
  224. S. H. Ralston, “Genetics of osteoporosis,” Proceedings of the Nutrition Society, vol. 66, no. 2, pp. 158–165, 2007. View at Publisher · View at Google Scholar
  225. F. Bertoldo, L. D'agruma, F. Furlan et al., “Transforming growth factor-β1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women,” Journal of Bone and Mineral Research, vol. 15, no. 4, pp. 634–639, 2000. View at Google Scholar · View at Scopus
  226. Y. Yamada, A. Miyauchi, Y. Takagi et al., “Association of a polymorphism of the transforming growth factor beta-1 gene with prevalent vertebral fractures in Japanese women,” The American Journal of Medicine, vol. 109, no. 3, pp. 244–247, 2000. View at Publisher · View at Google Scholar · View at Scopus
  227. Y. Yamada, A. Miyauchi, Y. Takagi, M. Tanaka, M. Mizuno, and A. Harada, “Association of the C-509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor-β1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women,” Journal of Molecular Medicine, vol. 79, no. 2, pp. 149–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  228. V. Hinke, T. Seck, C. Clanget, C. Scheidt-Nave, R. Ziegler, and J. Pfeilschifter, “Association of transforming growth factor-β1 (TGFβ1) T29→C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-β1 in a population-based sample of postmenopausal German women,” Calcified Tissue International, vol. 69, no. 6, pp. 315–320, 2001. View at Publisher · View at Google Scholar · View at Scopus
  229. D. Utennam, A. Tungtrongchitr, B. Phonrat, R. Tungtrongchitr, and S. Preutthipan, “Association of T869C gene polymorphism of transforming growth factor-β1 with low protein levels and anthropometric indices in osteopenia/osteoporosis postmenopausal Thai women,” Genetics and Molecular Research, vol. 11, no. 1, pp. 87–99, 2012. View at Publisher · View at Google Scholar · View at Scopus
  230. B. L. Langdahl, A. G. Uitterlinden, S. H. Ralston et al., “Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study,” Bone, vol. 42, no. 5, pp. 969–981, 2008. View at Publisher · View at Google Scholar · View at Scopus
  231. J. Massagué, “TGFbeta in cancer,” Cell, vol. 134, no. 2, pp. 215–230, 2008. View at Publisher · View at Google Scholar
  232. E. C. Connolly, J. Freimuth, and R. J. Akhurst, “Complexities of TGF-β targeted cancer therapy,” International Journal of Biological Sciences, vol. 8, no. 7, pp. 964–978, 2012. View at Publisher · View at Google Scholar
  233. S. H. Wrzesinski, Y. Y. Wan, and R. A. Flavell, “Transforming growth factor-β and the immune response: implications for anticancer therapy,” Clinical Cancer Research, vol. 13, no. 18, pp. 5262–5270, 2007. View at Publisher · View at Google Scholar · View at Scopus
  234. M. Gigante, L. Gesualdo, and E. Ranieri, “TGF-beta: a master switch in tumor immunity,” Current Pharmaceutical Design, vol. 18, no. 27, pp. 4126–4134, 2012. View at Publisher · View at Google Scholar · View at Scopus
  235. F. Itoh, T. Watabe, and K. Miyazono, “Roles of TGF-β family signals in the fate determination of pluripotent stem cells,” Seminars in Cell & Developmental Biology, vol. 32, pp. 98–106, 2014. View at Publisher · View at Google Scholar
  236. J. K. Venkatesan, A. Rey-Rico, G. Schmitt, A. Wezel, H. Madry, and M. Cucchiarini, “rAAV-mediated overexpression of TGF-β stably restructures human osteoarthritic articular cartilage in situ,” Journal of Translational Medicine, vol. 11, article 211, 2013. View at Publisher · View at Google Scholar · View at Scopus
  237. S. Acharjee, T.-K. Chung, S. Gopinadhan et al., “Sharp-1 regulates TGF-β signaling and skeletal muscle regeneration,” Journal of Cell Science, vol. 127, no. 3, pp. 599–608, 2014. View at Publisher · View at Google Scholar · View at Scopus
  238. J. Liu, K. Johnson, J. Li et al., “Regenerative phenotype in mice with a point mutation in transforming growth factor β type I receptor (TGFBR1),” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 35, pp. 14560–14565, 2011. View at Publisher · View at Google Scholar · View at Scopus
  239. F. Nasseri, G. A. Gholami, and M. Kadkhodazadeh, “Effect of bioactive ceramic and recombinant human transforming growth factor-beta (rhTGF-beta) on regeneration of parietal bone defects in rat,” Journal of Long-Term Effects of Medical Implants, vol. 21, no. 1, pp. 71–78, 2011. View at Publisher · View at Google Scholar · View at Scopus